Results 241 to 250 of about 10,028,727 (294)

Pros and Cons of Vitamin K Antagonists and Non–Vitamin K Antagonist Oral Anticoagulants

open access: yesSeminars in Thrombosis and Hemostasis, 2015
Anticoagulant treatment can be currently instituted with two different classes of drugs: the vitamin K antagonists (VKAs) and the newer, "novel" or non-vitamin K antagonist oral anticoagulant drugs (NOACs).
Walter Ageno, Nicoletta Riva
exaly   +6 more sources
Some of the next articles are maybe not open access.

Related searches:

Vitamin K antagonists

Hämostaseologie, 2012
SummaryFor the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flawed by the fact that the time
Steffel J, Luscher TF
openaire   +4 more sources

Comparison of Idraparinux With Vitamin K Antagonists for Prevention of Thromboembolism in Patients With Atrial Fibrillation: A Randomised, Open-Label, Non-Inferiority Trial

open access: yesLancet, The, 2008
BACKGROUND: Vitamin K antagonists, the current standard treatment for prophylaxis against stroke and systemic embolism in patients with atrial fibrillation, require regular monitoring and dose adjustment; an unmonitored, fixed-dose anticoagulant regimen ...
Graeme J. Hankey   +2 more
exaly   +3 more sources

A COMPREHENSIVE REVIEW OF VITAMIN K AND VITAMIN K ANTAGONISTS

Hematology/Oncology Clinics of North America, 2000
For more than 60 years, vitamin K-dependent proteins have been known to play an important role in regulating blood coagulation. During recent years it has become clear, however, that vitamin K is also involved in other physiologic processes, including bone metabolism and vascular biology.
C, Vermeer, L J, Schurgers
openaire   +4 more sources

Vitamin K antagonists

2023
Abstract Since the 1950s, vitamin K antagonists have been used for the prevention and treatment of venous and arterial thrombotic disorders. They have a narrow therapeutic window. To ensure efficacy and safety, close monitoring of the anticoagulation status is mandatory. Dietary and drug interactions are common.
Freek W.A. Verheugt, Marc A. Brouwer
openaire   +1 more source

Vitamin K antagonists and emergencies

European Journal of Emergency Medicine, 2018
The recent emergence of ‘non-VKA’ oral anticoagulants may have led to some forgetting that vitamin K antagonists (VKA) are by far the most widely prescribed oral anticoagulants worldwide. Consequently, we decided to summarize the information available on them. This paper presents the problems facing emergency physicians confronted with patients on VKAs
Lapostolle, Frédéric   +6 more
openaire   +2 more sources

The Role of Dietary Vitamin K in the Management of Oral Vitamin K Antagonists

Blood Reviews, 2012
Vitamin K antagonists (VKA) have been the mainstay of oral anticoagulant therapy for over 60years. In this review we critically assess the evidence for the importance of vitamin K nutrition during VKA therapy; the methodologies for measuring dietary intakes; the vitamin K intake data in patients on VKA and healthy people; and the experimental evidence ...
Michael V Holmes
exaly   +3 more sources

Vitamin K and Vitamin K Antagonists

2020
Vitamin Κ was discovered by Henrik Dam in 1929 in studies of sterol metabolism in chicks fed fat-free diets (1). The antihemorrhagic fat-soluble agent was called vitamin Κ, Κ being short for "Koagulation" (the German word for coagulation). Since then there have been two major eras of extensive research on this vitamin.
openaire   +1 more source

Home - About - Disclaimer - Privacy